Multiple Myeloma


A 57 year-old male patient with recurrent multiple myeloma affecting more than eighteen (18) sites of his bones suffered from excruciating pain throughout his entire body until he often collapsed. Due to his deteriorated health, he required four helpers to support him while taking a shower. Cancer cells had invaded the orbital bone of his right eye, which caused this eye to spontaneously shed tears. His oncologist suggested that it might be surgically necessary to remove his right eyeball. After receiving multi-cycle chemotherapy and radiotherapy, his scalp hair fell off completely, his fingers trembled involuntarily, his skin became hyper-pigmented and his lumbar spine area also darkened.


Before “stem cell and factor system” treatment, the patient’s centrifuged blood sample did not show clear blood fractionation, i.e. without normal gelatinous substance. However, two days after this treatment, normal gelatinous substance appeared in his blood sample. Four weeks later, his pigmented skin mostly recovered to its normal color. The darkened skin on his lumbar spine also gradually faded. His fingers stopped shaking uncontrollably and his scalp hair started growing back. His tumor marker index, white blood cell, platelet, IgA, IgG, IgM, Microglobulin Kappa Light Chain, Lambda Light Chain and Paraprotein counts all recovered to normal values. The patient was extremely grateful and relieved to hear his oncologist confirm there were no cancer cells detected in his body. His right eye no longer shed tears spontaneously and fully recovered. In addition, he no longer suffered from osteoporosis, which is usually a life-long complication for patients with multiple myeloma.


Multiple myeloma is a highly malignant cancer which originates from plasma cells. If it occurs alone in a soft tissue or a single bone, it is called Plasmacytoma. In most cases, myeloma cells can spread to many bones, causing symptoms, known as multiple myeloma. Clinical manifestations include bone destruction, renal failure, and untreatable life-long osteoporosis. At present, this disease cannot be cured by traditional western medicine or by new drugs.


CHMSUN noted that the patient with multiple myeloma was treated and cured in a synergistic way with cell therapy. CHMSUN expects the medical profession to continue advancing in providing successful and safe treatments for patients with intractable diseases.



Before Cell Treatment/After Cell Treatment - 4 Weeks Later



Before Cell Treatment/After Cell Treatment - 4 Weeks Later


This paper is for general knowledge and is not an academic publication.